Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-003410
Filing Date
2020-03-05
Accepted
2020-03-05 07:31:29
Documents
86
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1951899
2 ex4-1.htm EX-4.1 37697
3 ex10-11.htm EX-10.11 215799
4 ex23-1.htm EX-23.1 3844
5 ex31-1.htm EX-31.1 18305
6 ex31-2.htm EX-31.2 18179
7 ex32-1.htm EX-32.1 7098
8 ex32-2.htm EX-32.2 4036
  Complete submission text file 0001493152-20-003410.txt   6124391

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE xtnt-20191231.xml EX-101.INS 744828
10 XBRL SCHEMA FILE xtnt-20191231.xsd EX-101.SCH 60397
11 XBRL CALCULATION FILE xtnt-20191231_cal.xml EX-101.CAL 93729
12 XBRL DEFINITION FILE xtnt-20191231_def.xml EX-101.DEF 189808
13 XBRL LABEL FILE xtnt-20191231_lab.xml EX-101.LAB 436100
14 XBRL PRESENTATION FILE xtnt-20191231_pre.xml EX-101.PRE 334654
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34951 | Film No.: 20689636
SIC: 2836 Biological Products, (No Diagnostic Substances)